ArticleJournal of cancer policy2026
Exploring elements of governance in the development and implementation of national cancer control plans.
Article in Journal of cancer policy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Governance is an essential component of effective national cancer control plan (NCCP) development and implementation and this study aims to describe how and the extent to which governance is defined and outlined in NCCPs. It utilizes data from a global review of 98 NCCPs in 2023 conducted by 77 experts in cancer control planning using a 95-question form that examines components of NCCP development and implementation. To assess the governance elements represented in NCCPs, we used the Health Policy Triangle (HPT) framework, categorizing questions and developing a score based on its four components: content, context, actors, and mechanisms. Strengths were identified in the adequate involvement of several actors in NCCP development and implementation, such as Ministries of Health, and in appropriate mechanisms for NCCP governance, such as information about who is responsible for plan implementation. However, the inclusion of global cancer control targets and initiatives was often lacking. Overall governance scores were poor, but some variability was observed across WHO regions and country income levels. NCCPs from countries within the WHO Regional Office for Africa and low-income countries presented the highest scores across all four components. The HPT provides a framework to assess NCCPs and may pave the way for the development of further guidance regarding the governance of NCCPs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.